The Irish Renal Transplant Registry: recipient demographics and outcomes / K.A. Abraham... [et al.]

Similar documents
Chapter XII. ESRD-International comparisons. of ESRD Therapy. USRDS 1999 Annual Data Report International Comparisons of ESRD Therapy.

Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival

USRDS 1997 Annual Data Report International Comparisons of ESRD Therapy. Treated ESRD Incidence Rate for Selected Countries,

Renal Transplant Registry Report 2008

Treated ESRD Incidence Rate for Selected Countries, New Patients/Million Pop. 250 USA (All) USRDS 1996

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

Mary Keogan, on Mary behalf Keogan of all in NHISSOT On behalf of all in NHISSOT. 4th April 2014

Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.

Australia & New Zealand Pancreas. Transplant Registry Report

Australia & New Zealand Pancreas. Transplant Registry Report Inquiries or comments should be directed to the secretariat at:

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo

Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Australia & New Zealand Pancreas. Transplant Registry Report

J Am Soc Nephrol 14: , 2003

Scores in kidney transplantation: How can we use them?

Transplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

Kidney Transplant in the Elderly. Robert Santella, M.D., F.A.C.P.

CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%

Corneal transplantation: HLA and age

U.S. changes in Kidney Allocation

Highly Sensitized Patient Registry: Update and Successes

Chronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis

Cardiovascular Risk Reduction in Kidney Transplant Recipients

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

Peter Chang,* Jagbir Gill,* James Dong,* Caren Rose,* Howard Yan,* David Landsberg,* Edward H. Cole, and John S. Gill*

Kidney Transplantation

Liver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

Developing a Kidney Waiting List Calculator

Heart Transplant: State of the Art. Dr Nick Banner

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

Pancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Disclosures. Investigator-initiated study funded by Astellas

Older Living Kidney Donors and Recipients. Charles Le University of Colorado 6/24/11

Kidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania

The New Kidney Allocation Policy: Implications for Your Patients and Your Practice

Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017

COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

Chapter 6: Transplantation

Progress in Pediatric Kidney Transplantation

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia

QQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room

Disparities in Transplantation Caution: Life is not fair.

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Donation from Old Living Donors How safe is it? Safe for recipient or donor?

The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation

Mycophenolate mofetil in low-risk renal transplantation in patients receiving no cyclosporine: a single-centre experience

Health Care Policy. Introduction. Assessing health care efficacy

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Acute rejection and late renal transplant failure: Risk factors and prognosis

Research Article Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy

CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study. Results at 1 Year

New Zealand Kidney Allocation Scheme

ORIGINAL ARTICLE. Eric F. Martin, 1 Jonathan Huang, 3 Qun Xiang, 2 John P. Klein, 2 Jasmohan Bajaj, 4 and Kia Saeian 1

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

ABO mismatched Renal Transplants

kidney OPTN/SRTR 2012 Annual Data Report:

Association of Kidney Transplantation with Survival in Patients with Long Dialysis Exposure

Marginal donors: Young vs. Old

Progress report on the analysis of cancer care

Overview. 1. Training time - 2 vs 3 core years. 2. Rural vs metropolitan training -? mandate rural. 3. Should acute Tx be mandatory?

Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades

Are two better than one?

NHS BLOOD AND TRANSPLANT LIVER ADVISORY GROUP WAITING TIMES AND DEATHS ON THE LIST BY BLOOD GROUP SUMMARY

SHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson

Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients

3/5/18. Background. Registry Reports. Dialysis Registry Update and Future Directions

Substance Use Among Potential Kidney Transplant Candidates and its Impact on Access to Kidney Transplantation: A Canadian Cohort Study

Mortality After Kidney Transplantation: A Comparison Between the United States and Canada

Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand,

Living Donor Paired Exchange (LDPE)

LUNG ALLOCATION SCORE SYSTEM UPDATE

2015 Poster Presentations

Heart Transplantation

Hasan Fattah 3/19/2013

Compared efficacy of preservation Solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry.

Should red cells be matched for transfusions to patients listed for renal transplantation?

RECURRENT GLOMERULONEPHRITIS RISK OF RENAL ALLOGRAFT LOSS FROM RECURRENT GLOMERULONEPHRITIS. Data Collection

Three Sides to Allocation. ECD Extended Criteria Donor

What Happens on Call?? June 02, 2016

One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry

Patient Education Transplant Services. Glossary of Terms. For a kidney/pancreas transplant

chapter seven transplantation page

Long-Term Survival of Children with End-Stage Renal Disease

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

Steroid Minimization: Great Idea or Silly Move?

Current strategies to kidney allocation

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

Transcription:

The Irish Renal Transplant Registry: recipient demographics and outcomes / K.A. Abraham... [et al.] Item type Authors Rights Presentation Abraham, K A Beaumont Hospital Downloaded 10-Jul-2018 23:39:57 Link to item http://hdl.handle.net/10147/44657 Find this and similar works at - http://www.lenus.ie/hse

The Irish renal transplant registry; recipient demographics and outcomes. K.A. Abraham, P. O'Kelly, K. Tyrrell, V. Frances,E Dunne, P. Cunningham, S. Spencer, D. Hickey, J.J. Walshe, P.J. Conlon on behalf of the National Renal Transplant Registry, Beaumont Hospital, Dublin 9.

Irish renal transplant registry 2462 renal transplants 14.03.66-16.01.01 15.7% more than 1 transplant Median age 20 in 1966-42 in 2000 Over 65s 0 in 1966-8 % in 2000 (2.2 % - 8 % in last decade) Male : Female ratio 64 : 36

Causes of ESRD 10% 7% 15% 39% 6% 14% 7% Prevalence of Dialysis - 226/ million Prevalence of Transplantation - 323/ million Prevalence of ESRD - 550/ million (US - 1190) GN DM Inh(ADPKD) BP Depot Obstr Pyelo Misc Unknown

Irish renal transplant registry Transplantation increased in the first 2 decades but has levelled off since 1990 Mean - 136 transplants p.a. in last 15 years (range 114-158) 37.5 transplants per million population p.a. 2000 1998 1996 1994 1992 1990 1988 1986 0 50 100 150 200

Transplant Activity 2000 1500 1000 500 0 1986 1987 1988 Y 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 year The cumulative number of functioning grafts ( ) and transplants performed ( ) between 1986 and 2000

Prevalence of ESRD - International Comparisons 1600 1400 1200 1000 800 600 400 200 0 Jpn US Italy Ger Swe Fra 550 Irl Aus UK Isr Pol Jpn US Italy Ger Swe Fra Irl Aus UK Isr Pol Ireland 2000, rest 1998

Transplantation Rates for Selected 50 45 40 35 30 25 20 15 10 5 0 37.5 Countries USA Ger Irl Den Can UK Aus Brz Pol Rom Jpn Renal Tx /million popn Ireland 1999, rest 1997

Percent of prevalent ESRD patients with 60 50 40 30 20 10 59% a functioning transplant 0 IRL Swe UK NL Aus NZ Den Bel Can Fra HK USA Ger CHL Urg Ireland 2000, rest 1997

Patients with a Functioning Transplant per million population, 1997 400 350 300 250 200 150 100 50 0 IRL* SWE UK NL AUS NZ DEN* BEL CAN FRA* HK* POL USA BRZ GER* ITA* CHL Functioning Transplants/Million Pop URG *Data are from 1996 Country

Aims Assess patient survival Study renal graft survival Comparison with international figures. Have these parameters improved with time? Identify risk factors

Methods Created a data bank from various sources All transplant recipients between 1986 and 1999 followed till death or failure of latest graft Cox proportional hazards model and Kaplan-Meier survival curves JMP & Stata statistical programmes Eras for comparison: 1986-89, 90-94, 95-99

Results - 1 1659 transplants in 1490 patients Median age at first Transplant - 42 (2-76) Male : Female 64 : 36 Predicted time to failure - 10.5 yrs ( 95% C.I. 9.3-11.7 ) Median patient survival - 22.5 yrs ( 95% C.I. 18.6-26.1)

Patient survival

Graft survival

Results - Graft survival 87 87 16 14.1 86 14 85 84 12 9.8 84 83 82 81 80 81 10 8 6 4 9 79 2 78 86-89 90-94 95-99 1 year graft survival % 0 86-89 90-94 95-99 Graft 1/2 life in years

1, 3 & 5 year graft survival 90 80 70 63 68 75 60 50 40 30 1 year 3 year 5 year 20 10 0 86-89 90-94 95-99 Survival in %

International Comparisons 1 yr survival 1988 - % 1 yr survival 1996 - % Graft 1/2 life 1988 - yrs Graft 1/2 life 1996 - yrs UNOS - Ireland Hariharan et al* 75.7 81 87.7 87 7.9 9 13.8 14.1 * N Engl J Med 2000; 342(9): 605-612

Results - Risk factors Variable Hazard Ratio p value 95% C.I. Era of transplant 0.813.001 0.719-0.920 Recipient age 1.005.114 0.999-1.010 Recipient sex 1.036.557 0.879-1.269 PRA % 1.210.008 1.050-1.392 HLA missmatch 0.927.455 0.763-1.129 Transplant no. 1.280.004 1.015-1.615.(1 vs. 2 or more) CMV 1.793.000 1.358-2.368 Donor age 1.014.000 1.008-1.020 Donor sex 0.726.003 0.587-0.896

Multivariate analysis (cox proportional hazard) Variable Haz. Ratio P value 95% C.I. Era 1.54 0.004 1.14-2.07 CMV + 1.53 0.004 1.15-2.03 Donor sex 0.74 0.032 0.56-0.97 Donor age 1.02 0.000 1.01-1.03

Summary Short & long term improvement in graft survival Patient survival uniform in the 3 eras PRA, Transplant no., CMV +, - risk factors Donor factors- younger age, male sex - predict improved graft survival

Acknowledgements Nephrologists Transplant surgeons Laboratory Support B.O Dwyer A. Walsh G. Doyle M. Carmody S. Hanson A. Dorman J.J. Walshe P. McLean M. Keoghan J. Donohoe D. Murphy All staff in Tissue P.J. Conlon D.P. Hickey Typing Dept. J.A.B. Keogh M. Donovan A. Watson T. Creagh All doctors and nurses G. Mellotte D. Little on the renal and H.R. Brady Transplant Coordinators transplant teams Y. O Meara P. Cunningham D. Gill A. Counihan We gratefully P. Deasy L. Hacke acknowledge the D. Murnaghan K. Tyrrell financial support B. Duffy Outcome Research Centre received from the C. Cronin P. Kelly Transplant Foundation F. Walker S. Spencer and Novartis -- V. Frances, E. Dunne Pharmaceuticals